Mylan Inc exits Biocon fully, revised disclosure corrects holding to Nil

Fii Holding DeclinedOwnership Changes View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.7%Reaction day

₹414.30

prior close

₹418.00

announcement price

In-mkt

timing

Nifty Midcap 150market+0.0%+0.7% vs market

Pharmaceuticals peers, median of 175sector+0.3%+0.4% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Midcap 150 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.7+0.0+0.7+0.3+0.4

Next day

+0.4-0.1+0.4+0.4-0.0

-0.3-0.1-0.2+0.7-1.1

-0.6+0.0-0.6+1.0-1.5

-3.0-1.2-1.8+0.5-3.5

-3.1-1.8-1.3+0.7-3.8

-4.3-1.5-2.8+1.2-5.5

15d

-7.8-4.1-3.7+1.0-8.8

-9.5-6.2-3.3-0.5-9.0

-20.6-11.5-9.1-5.8-14.8

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mylan Inc has submitted a revised disclosure correcting a typographical error in its 15 July 2026 filing. Mylan sold 9,19,67,019 equity shares of Biocon (5.64% of equity share capital) via open market on 14 July 2026. The post-disposal holding has been corrected to Nil, confirming Mylan has fully exited Biocon. Mylan is not part of Biocon promoter group.

Likely market impact

Foreign shareholder Mylan Inc has completely exited Biocon, reducing stake from 5.64% to zero via open market sale.